Shiri Habib-Valdhorn, Author at Jewish Business News

Mylan might make do with only 50% of Perrigo

Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.

Shiri Habib-ValdhornAugust 13, 2015

Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.

The Check Point CEO said there is growing awareness of the seriousness of cyber crime threats.

Erez Vigodman: Size isn't everything; it's important to be better.

If the FCA money laundering investigation is complete, this could affect the chances of Playtech's bid.

Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.

Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo

A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.

Two years ago, the Chinese-Israeli fund invested only a few million dollars in e-commerce company Baozun.

Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.